CTLA4 and neoplasm: The most studied receptors which prevent the destruction of the tumor cells by inhibiting T-cell activity are programmed cell death receptor 1 (PD1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) [13].